In the A-share market, investors often hear the words "drink and eat medicine", which is not literally the meaning of the word, but refers to the purchase of white wine, medical sector stocks, this situation generally occurs in the process of the market continues to fall, investors through the purchase of such stocks for hedging, of course, for some prudent investors
Medicine ETFs are the most popular form of ETFs in the world, but they are not the only form of ETFs in the world.
Pharmaceutical ETF funds are mainly:
Guangdong CSI All-Index Pharmaceutical ETF (159938), closely tracking the All-Index Pharmaceutical Index, with a tracking error of 0.03%, was established on December 1, 2014, with an intermediate to advanced risk rating, belonging to the over-the-counter (OTC) fund, i.e., investors can, through their stock accounts, purchase in the stock market, and at present, the fund has a major long position in stocks such as Hengrui Medicine, Watson Biologicals, Tablet Yellow and WuXi AppTec.
Efounda CSI 300 Pharmaceuticals & Health ETF (512010), which closely tracks the CSI 300 Pharmaceuticals & Health Index with a tracking error of 0.08 percent, was established on Sept. 23, 2013, and is an over-the-counter fund, which is currently heavy in stocks such as Hengrui Pharmaceuticals, WuXi Biologicals, Aierophthalmics and Yunnan Baiyao.
Huaxia Pharmaceuticals ETF (510660), which closely tracks the SSE Pharmaceuticals & Healthcare Sector Index with a tracking error of 0.19%, was established on March 28, 2013 and is an over-the-counter fund. The fund's current long positions include Hengrui Pharmaceuticals, Tablets, Fosun Pharmaceuticals and Shanghai Pharmaceuticals.
Carlson CSI Healthcare ETF (512610), which closely tracks the CSI Healthcare Index with a tracking error of 0.04% and an inception date of June 13, 2014, is an over-the-counter fund, which currently has long positions in stocks such as Hengrui Pharmaceuticals, PharmaTech, Aier Ophthalmology and Yunnan Baiyao.